Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RHOXF1 antisense RNA 1 (RHOXF1-AS1) is a long non-coding RNA transcribed from the X chromosome, acting as an antisense transcript to the RHOXF1 homeobox gene[1][2][4][7]. It does not code for a protein but plays a regulatory role at the RNA level. RHOXF1-AS1 is expressed predominantly in certain tissues, including breast and thyroid, and at lower levels in placenta and ovary[6]. Overexpression experiments have shown that RHOXF1-AS1 affects the expression of genes involved in DNA replication, synthesis, and the cell cycle, promoting differentiation and reducing proliferation in human pluripotent stem cells[6]. Evidence suggests that it may act in the cytoplasm to mediate mRNA decay or inhibit translation, and might also serve as a scaffold in the nucleus to guide chromatin-modifying complexes for transcriptional regulation[6]. RHOXF1-AS1 has been linked to various cancers, particularly as a potential biomarker for prognosis in lung adenocarcinoma[8]. At present, it is not recognized as a classic drug target (receptor, enzyme, transporter, etc.), and there are no known drugs that specifically interact with RHOXF1-AS1.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RHOXF1 antisense RNA 1 (RHOXF1-AS1).